Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis

Rafal Tokarz1, Jeffrey S Hyams2, David R Mack3

  • 1Center for Infection and Immunity, Mailman School of Public Health, Columbia University, NY, USA.

Insights

This study found no link between viral infections and the onset of pediatric ulcerative colitis (UC). Virus presence in stool did not correlate with UC development or disease severity in children.

Area of Science:

  • Gastroenterology
  • Virology
  • Pediatric Health

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
  • Viral infections are hypothesized as potential triggers for UC onset.

Purpose of the Study:

  • To investigate the association between viral infections and the onset of pediatric ulcerative colitis (UC).
  • To analyze the stool virome in children with newly diagnosed UC using high-throughput sequencing.

Main Methods:

  • Employed VirCapSeq-Vert, a high-throughput sequencing virus capture platform.
  • Examined stool samples from children with moderate to severe UC at presentation and after remission.
  • Included a control group of children diagnosed with irritable bowel syndrome.

Main Results:

  • A wide range of animal viruses were detected, belonging to 12 viral families.
  • Viruses were present in 50% of UC samples at presentation and 40% of control samples.
  • The UC cohort showed a higher prevalence of anelloviruses, but no single virus was linked to UC onset or severity.

Conclusions:

  • The presence of viruses in stool is not associated with the onset of pediatric ulcerative colitis.
  • No specific virus was identified as a causative agent for UC in children.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
941
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
482
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.1K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
813
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
763